These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12851916)

  • 21. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients.
    Vonend O; Rump LC; Ritz E
    Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoalbuminemia and not hyperhomocysteinemia as a risk factor for dementia in hemodialysis patients.
    Huang YC; Kuo YW; Lee TH; Lee M; Hsiao MC; Wang CL; Lee JD
    J Ren Nutr; 2008 Jul; 18(4):347-54. PubMed ID: 18558299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular calcifications in uremia: old concepts and new insights.
    Derici U; El Nahas AM
    Semin Dial; 2006; 19(1):60-8. PubMed ID: 16423183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
    Nishizawa Y; Shoji T; Ishimura E; Inaba M; Morii H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S4-7. PubMed ID: 11576913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Accelerated atherosclerosis in rheumatoid arthritis].
    Shepshelovich D; Sherer Y; Shoenfeld Y
    Harefuah; 2005 Aug; 144(8):561-3, 598. PubMed ID: 16146154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension, atherosclerosis and kidney].
    Zuccalà A; Fiorenza S; Rapanà R; Santoro A
    G Ital Nefrol; 2005; 22 Suppl 31():S9-14. PubMed ID: 15786409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
    Perna AF; Capasso R; Acanfora F; Satta E; Lombardi C; Ingrosso D; Violetti E; Romano MM; De Santo NG
    Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension and cardiovascular risk assessment in dialysis patients.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M;
    Nephrol Dial Transplant; 2004 May; 19(5):1058-68. PubMed ID: 15004266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Veller MG; Stevens BA; Tobias M; Reddi K; Stanwix AE
    J Rheumatol; 2005 Mar; 32(3):435-42. PubMed ID: 15742434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.